Home » Newsletters » BioWorld Science

BioWorld Science

March 9, 1999

View Archived Issues

Fluvastatin induces delayed improvement in coronary flow reserve

BioNumerik initiates phase I clinical trials of promising new anticancer compound

Targeted Genetics: Q4 1998 highlights

AxyS Pharmaceuticals: Q4 1998 highlights

rsIL-4R as a potential treatment for atopic eczema

Transcutaneous nitroglycerin evaluated in controlled trial for MED

Anesta begins launch of novel analgesic

Agents for stimulating upper and lower GI motility in development at Labs. Jacques Logeais

Licensing opportunity from Yeda: vitamin D3 analogue with multiple potential indications

Esteve patents novel compounds with multiple effects on the CNS

New radiolabeled cocaine analogues for diagnostic imaging designed at Emory University

TASP-V, a novel and selective NPY Y2 agonist for rhinitis and asthma

Optically pure trimebutine metabolite useful for chronic pain

Kaneka presents new HSF inhibitors

APA Assay accurately diagnoses patients with fibromyalgia

Rhone-Poulenc Rorer claims series for diabetes and diabetic complications

Angelini studies effects of structural modifications to trazodone on binding profile

AN-207, a targeted cytotoxic compound with potential in treating prostate cancer

TNF-alpha inhibitor discovered at Nisshin Flour Milling as new lead antiinflammatory compound

Microbially produced 5alpha-reductase inhibitor discovered at Snow Brand

Variagenics, Nova Molecular team up to study treatments for neurological diseases

Novel hemostatic cofactors available for licensing from OMRF

New patent strengthens Millennium's position on UCPH

Avanir submits additional efficacy data for docosanol cream to FDA

Corvas presents phase I trial results of novel injectable anticoagulant at ACC meeting

Interim safety results for Flocor in sickle cell patients with acute chest syndrome

OraVax and Peptide Therapeutics merger to be completed early in second quarter

Sustiva recommended for full marketing approval in Europe

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...